September 2026 Journal Club

Cannabis versus Placebo for Acute Migraine: A Randomized Controlled Trial

Cerium Journal Club -1st Tuesday of Every Month!

Time: September 1st, Noon EST        

Location – Virtual Meetinghttps://us02web.zoom.us/j/83722922366?pwd=QjZ3V0xNWHZ0OVZ0b3BpbWd3STRqUT09

Event Description

For our September 2026 journal club we will discuss a randomized, double-blind, placebo-controlled crossover trial that evaluated vaporized cannabis for the acute treatment of migraine. Ninety-two adults were randomized to treat separate migraine attacks with THC-dominant cannabis, CBD-dominant cannabis, combined THC+CBD cannabis, or placebo cannabis flower.

The combined 6% THC + 11% CBD treatment was superior to placebo for pain relief, pain freedom, and freedom from the most bothersome migraine symptom at two hours. Some benefits were sustained for 24 to 48 hours. THC-dominant cannabis improved pain relief but did not significantly improve pain freedom or freedom from the most bothersome symptom, while CBD-dominant cannabis was not superior to placebo. No serious adverse events were reported.

During the session, we will discuss:

  • The strengths and limitations of the study

  • The clinical significance of the reported treatment effects

  • Differences among the THC-dominant, CBD-dominant, and combined formulations

  • Risks, psychoactive effects, and practical considerations 

  • Implications for cannabinoid and migraine research

  • And anything attendees want to share about the study!

We look forward to the discussion.

Featured Article

Key takeaway: Inhaled cannabis with THC (3.1% and 7.2%) significantly reduced alcohol consumption by 19–27% compared to placebo, with nuanced effects on craving and urge.

Speakers

  • Phil Molloy, MD – Clinical education expert

  • Teresa Simon, MPH – Public health epidemiologist

  • Len Kamen, MD – Clinical pain specialist

  • Jahan Marcu, PhD – Cannabis researcher

Questions?

Email: PRCtrials.info@gmail.com

This journal club is supported by PRC+.
PRC+ has education modules and resources available for healthcare professionals:
https://www.prc-trials-plus.com/education

Next
Next

Journal Club: Can Brain Imaging Detect THC Impairment Better Than Field Sobriety Tests?